Bayer announced positive topline results from the global phase III QUASAR study evaluating the efficacy and safety of aflibercept 8 mg in patients with macular edema following retinal vein occlusion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback